24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo Keith BowmanVice President of Process Development at Wave Life SciencesSpeaker
Profile
Keith Bowman is the Vice President of Process Development at Wave Life Sciences. Keith began his career in Oligonucleotides at Ribozyme Pharmaceuticals in 1999 doing downstream process and analytical development. Keith has since held positions of increasing responsibility with SIrna Therapeutics, and Novartis before joining Wave in 2015. Keith currently leads a team of scientists’ who are responsible for process optimization, scale up, process characterization for Wave’s clinical pipeline
Agenda Sessions
Process Safety Evaluation and Scale up of Oligonucleotides Manufacturing, a CMC Perspective
, 4:15pmView Session